Newsroom
August 3, 2021
Dr. Kumar Sharma, Department of Medicine, Division of Nephrology and Center for Renal Precision Medicine, and Dr. Subrata Debnath, Nephrology, are quoted in this news release disseminated on Spoke.com about NIRVANA, a National Institutes of Health-funded pilot clinical study to treat acute kidney injury in COVID-19 patients. Read story
August 3, 2021
Dr. Kumar Sharma, Department of Medicine, Division of Nephrology and Center for Renal Precision Medicine, and Dr. Subrata Debnath, Nephrology, are quoted in this news release disseminated on Benzinga about NIRVANA, a National Institutes of Health-funded pilot clinical study to treat acute kidney injury in COVID-19 patients. Read story
August 3, 2021
Dr. Kumar Sharma, Department of Medicine/Division of Nephrology and Center for Renal Precision Medicine, and Dr. Subrata Debnath, Nephrology, are quoted in this news release disseminated on Yahoo! Finance and other websites about a National Institutes of Health-funded pilot clinical study to treat acute kidney injury in COVID-19 patients. Read story
August 3, 2021
This Medical Xpress story is about the TODAY studies published in the New England Journal of Medicine that showed that within 15 years of a Type 2 diabetes diagnosis, 60% of participants had at least one diabetes-related complication, and nearly a third of participants had two or more. Read story
July 30, 2021
Dr. Timothy Tseng, Urologist with UT Health Physicians, gives tips on kidney stone prevention in this KENS 5 Medical Minute. Medical Minute is a collaboration between UT Health San Antonio and KENS 5. Watch here
July 27, 2021
Researchers at UT Health San Antonio, The University of Washington at Seattle and the Icahn School of Medicine at Mount Sinai in New York have launched NIRVANA, a National Institutes of Health-funded pilot clinical study to treat acute kidney injury (AKI) in COVID-19 patients.
